StockData
Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc. (ARCT) stock

ARCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3010% below fair value
$7.97−0.34 (-4.09%)

Close on Nov 17, 2026Market cap $226.53MP/E –Yield –

Arcturus Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Arcturus Therapeutics's market cap was $264.62M on Nov 11, 2026, against $184.93M a year earlier. Over the last 5 years it ranged from $163.72M to $1.05B, with a median of $479.45M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$264.62M+58.5%
2025Dec 31, 2025$166.95M-63.7%
2024Dec 31, 2024$459.62M-45.5%
2023Dec 29, 2023$842.58M+87.5%
2022Dec 30, 2022$449.30M-53.9%
2021Dec 31, 2021$975.18M-8.1%
2020Dec 31, 2020$1.06B+545.7%
2019Dec 31, 2019$164.42M–

More Arcturus Therapeutics figures

See a number that looks wrong?